TickerFacts.

Medline Inc. (MDLN): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.01B
Year ended 2025-12-31
$1.02B
Trailing 12 months to 2026-06-27
2023-12-31: $951.00M2024-12-31: $977.00M2025-12-31: $1.01B$1.01B
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.01B+3.5%2026-02-25, From 2025-01-01
2024-12-31$977.00M+2.7%2026-02-25, From 2024-01-01
2023-12-31$951.00Mn/a2026-02-25, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Medline Inc. (MDLN)2025-12-31$1.01B+3.5%
Stryker Corp (SYK)2025-12-31$1.57B+10.1%
3M Co (MMM)2025-12-31$1.31B-4.0%
Becton Dickinson & Co (BDX)2025-09-30$2.46B+7.7%
Boston Scientific Corp (BSX)2025-12-31$1.37B+7.8%
Baxter International Inc (BAX)2025-12-31$981.00M-1.6%
Solventum Corp (SOLV)2025-12-31$489.00M-11.9%
ResMed Inc (RMD)2026-06-30$201.34M+1.4%
Dexcom Inc (DXCM)2025-12-31$251.80M+15.7%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗